Cytospire Therapeutics
PrivateLast Round
Series A
May 5, 2026
Total Funding Raised
$83M
Momentum
Top 5%
of companies Caplight tracks
Company Overview
Cytospire Therapeutics is a biotechnology company developing a portfolio of differentiated multispecific engager antibodies to enhance and direct the activity of innate and adaptive effector immune cells for the treatment of cancer.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials, Precision Medicine
Business Model
B2B
Customer Profile
Revenue Share
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Cytospire Therapeutics Comparables
Compare Cytospire Therapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Janux Therapeutics | 77% | |
| Ipsen | 76% | |
| Lava Therapeutics | 75% | |
Cytospire Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A | May 5, 2026 |
Cytospire Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Servier Ventures | Series A |
| Medical Incubator Japan | Series A |
| British Business Bank | Series A |
| 4BIO Capital | Seed, Series A |
| Abingworth | Series A, Seed |
| Pathway Bioventures | Series A |
| LifeArc Ventures | Series A, Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 1, 2026
Grew 47% QoQ, from 19 to 28 employees.
- May 27, 2026
Grew 17% QoQ, from 18 to 21 employees.
Cytospire Therapeutics Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Cytospire Therapeutics's valuation, stock price, and market status.